Results 151 to 160 of about 8,784 (177)

Atypical hemolytic uremic syndrome: a rare complication of postendoscopic retrograde cholangiopancreatography pancreatitis. [PDF]

JPGN Rep
Nanagiri A, Pravder S, Solomon S, Tewari V, Bostwick H.   +4 more
europepmc   +1 more source

Real-World effectiveness of eculizumab in atypical hemolytic uremic syndrome: a retrospective study from Western China. [PDF]

Front Endocrinol (Lausanne)
Hu Y, Zhang Y, Wang W, Li G, Chen S.
europepmc   +1 more source

Ocular Manifestations in Atypical Hemolytic Uremic Syndrome Treated With Ravulizumab: A Case Report and Review of the Literature. [PDF]

Cureus
Flindris K, Papafotiou E, Mylona E, Chatzipetrou C, Kaliardas A, Koumpoulis I, Melissourgos I.   +6 more
europepmc   +1 more source

Clinical and genetic characteristics of patients diagnosed with atypical hemolytic uremic syndrome (aHUS): epidemiological data from the Belgian cohort of the Global aHUS Registry. [PDF]

J Nephrol
Massart A, Weekers L, Claes KJ, Van Meerhaeghe T, Snauwaert E, Mekahli D, Goffin E, Collard L, Godefroid N, Adams B, Van Cauwelaert S, Van Hoeck K, Block S, Al-Dakkak I, Dahan K, Stordeur P, Vande Walle J.   +16 more
europepmc   +1 more source

Hypertensive Emergency and Atypical Hemolytic Uremic Syndrome Associated with Cocaine Use: A Diagnostic and Therapeutic Challenge. [PDF]

Diseases
Jiménez Mayor E, De La Flor JC, Rocha Rodrigues A, Rodríguez Tudero C, Zamora González-Mariño R, Apaza J, Moral Berrio E, Deira Lorenzo J.   +7 more
europepmc   +1 more source

Atypical hemolytic uremic syndrome: diagnosis, management, and discontinuation of therapy. [PDF]

Hematology Am Soc Hematol Educ Program
Java A.
europepmc   +1 more source

Treatment of atypical hemolytic uremic syndrome with eculizumab in a patient presenting with neuropsychiatric prodrome: a case report. [PDF]

Front Immunol
Yang H, Zhang J, Wu H, Xu H, Xu Z.
europepmc   +1 more source

Real-World Effectiveness of Ravulizumab Among C5 Inhibitor-Naive Patients With Atypical Hemolytic Uremic Syndrome: A Physician Panel-Based Chart Review (aHUS IMPACT Study). [PDF]

Kidney Med
Hanna RM, Chaturvedi S, Ong ML, Nag A, Song R, Huynh L, Burdeau JA, Duh MS, Wang Y.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Atypical Hemolytic–Uremic Syndrome

New England Journal of Medicine, 2009
The hemolytic–uremic syndrome, which is characterized by nonimmune hemolytic anemia, thrombocytopenia, and renal impairment, occurs most frequently in young children. Most cases are secondary to infection with Escherichia coli O157:H7 and other Shiga-toxin–producing strains.
Marina Noris, Giuseppe Remuzzi, Noris Marina   +2 more
exaly   +3 more sources

Pathogenesis of Atypical Hemolytic Uremic Syndrome

Journal of Atherosclerosis and Thrombosis, 2019
Atypical hemolytic uremic syndrome (aHUS) is a type of thrombotic microangiopathy (TMA) defined by thrombocytopenia, microangiopathic hemolytic anemia, and renal failure. aHUS is caused by uncontrolled complement activation in the alternative pathway (AP).
Yoichirô Ikeda, Masaomi Nangaku
exaly   +4 more sources